Hypertension treatment by nonphysician professionals, such as pharmacists and nurses

Health professionals who are not doctors, such as pharmacists and nurses, providing blood pressure medicine, as long as they have proper training and prescribing authority, follow set management protocols and work under a doctor's oversight.

Also called Nonphysician hypertension treatment

Intervention
In this atlas

Overview

Technical summary

WHO 2021 recommendation 8 (conditional, low-certainty evidence) suggests that nonphysician professionals such as pharmacists and nurses can provide pharmacological treatment of hypertension when proper training, prescribing authority, specific management protocols and physician oversight are in place. Which professionals may prescribe in a given country was not checked.

About this intervention

Type: Service
Mechanism: Not reported

Claims and evidence

Context Adults with confirmed hypertension (WHO 2021 recommendations 1a, 4, 5 and 8)

Recipient: Adult
Population: Adults with a confirmed diagnosis of hypertension. Recommendation 1a covers systolic 140 mmHg or higher or diastolic 90 mmHg or higher. Recommendations 4, 5 and 8 cover adults with hypertension who need medicine. WHO says the guideline targets non-pregnant adults who were appropriately diagnosed and counselled about lifestyle changes.
Care setting: Not stated for this recommendation in the source
Geography: Global WHO guidance; national adoption not recorded
Life stage: Adult
Follow-up: Not applicable (recommendation context)

Eligibility: 3 inclusion criteria; 1 exclusion criterion

Included: Adult
Confirmed diagnosis of hypertension
Counselled about lifestyle modifications (WHO scope statement)
Excluded: Pregnant patients: WHO says the recommendations target non-pregnant patients

Recommendation Guidance Low certainty

WHO suggests that medicine for hypertension can be provided by nonphysician professionals such as pharmacists and nurses, provided there is proper training, prescribing authority, specific management protocols and physician oversight.
Applies to Adult
- Adults with a confirmed diagnosis of hypertension. Recommendation 1a covers systolic 140 mmHg or higher or diastolic 90 mmHg or higher. Recommendations 4, 5 and 8 cover adults with hypertension who need medicine. WHO says the guideline targets non-pregnant adults who were appropriately diagnosed and counselled about lifestyle changes.
- Not stated for this recommendation in the source
- Global WHO guidance; national adoption not recorded
- Adult
Follow-up Not applicable (recommendation context)
Certainty method
The certainty is the GRADE level WHO prints in the strength label of this recommendation. It is WHO's assessment of the evidence base, not an assessment by this atlas.

Limitations
WHO labels this statement "Conditional recommendation, low-certainty evidence". The certainty above is that label. The conditions are part of the recommendation, and none of them was checked against any country's rules. Global WHO guidance written for adults who are not pregnant; national adoption is not recorded. No evidence review behind the recommendation was read by this cluster. The WHO publication page and the PDF disagree on the page count (48 versus 61); this was not resolved.

Last checked
2026-10-11

Next evidence check due
Not scheduled
Sources and citations (5)
1. Supports Guideline for the pharmacological treatment of hypertension in adults (World Health Organization, 2021)
  
  Guideline · World Health Organization · Edition Two snapshots of one edition, fetched on 2026-10-11: the WHO publication page, and the English PDF through the IRIS REST bitstream (843539 bytes, 61 pages counted from the file). The publication page states 48 pages. This cluster did not resolve the difference. A separate WHO summary edition exists and was not fetched. · Published 2021-08-24 · isbn: 978-92-4-003398-6
  
  Locator
  PDF page 31, section 3.8, recommendation 8, statement (part 1)
  
  How it applies
  Who may provide treatment.
  
  Retrieved
  2026-10-11T19:11:40Z
  
  Source effective date
  2021-08-24
  
  Source state
  Current
  
  Snapshot hash
  57f6376d5c9bc4ea6c44873625547c8a5443d5a6ad8c8c422733681563db05fb
  
  Reuse basis
  CC BY-NC-SA 3.0 IGO, as the PDF states. Short quotations with attribution only. The non-commercial and share-alike terms need a decision on the atlas public data licence before any reuse beyond short quotation. Neither snapshot is committed.
2. Supports Guideline for the pharmacological treatment of hypertension in adults (World Health Organization, 2021)
  
  Guideline · World Health Organization · Edition Two snapshots of one edition, fetched on 2026-10-11: the WHO publication page, and the English PDF through the IRIS REST bitstream (843539 bytes, 61 pages counted from the file). The publication page states 48 pages. This cluster did not resolve the difference. A separate WHO summary edition exists and was not fetched. · Published 2021-08-24 · isbn: 978-92-4-003398-6
  
  Locator
  PDF page 31, section 3.8, recommendation 8, statement (part 2)
  
  How it applies
  The conditions that must be met.
  
  Retrieved
  2026-10-11T19:11:40Z
  
  Source effective date
  2021-08-24
  
  Source state
  Current
  
  Snapshot hash
  57f6376d5c9bc4ea6c44873625547c8a5443d5a6ad8c8c422733681563db05fb
  
  Reuse basis
  CC BY-NC-SA 3.0 IGO, as the PDF states. Short quotations with attribution only. The non-commercial and share-alike terms need a decision on the atlas public data licence before any reuse beyond short quotation. Neither snapshot is committed.
3. Background Guideline for the pharmacological treatment of hypertension in adults (World Health Organization, 2021)
  
  Guideline · World Health Organization · Edition Two snapshots of one edition, fetched on 2026-10-11: the WHO publication page, and the English PDF through the IRIS REST bitstream (843539 bytes, 61 pages counted from the file). The publication page states 48 pages. This cluster did not resolve the difference. A separate WHO summary edition exists and was not fetched. · Published 2021-08-24 · isbn: 978-92-4-003398-6
  
  Locator
  PDF page 31, section 3.8, recommendation 8, strength label
  
  How it applies
  The strength label WHO prints under the statement: Conditional recommendation, low-certainty evidence
  
  Retrieved
  2026-10-11T19:11:40Z
  
  Source effective date
  2021-08-24
  
  Source state
  Current
  
  Snapshot hash
  57f6376d5c9bc4ea6c44873625547c8a5443d5a6ad8c8c422733681563db05fb
  
  Reuse basis
  CC BY-NC-SA 3.0 IGO, as the PDF states. Short quotations with attribution only. The non-commercial and share-alike terms need a decision on the atlas public data licence before any reuse beyond short quotation. Neither snapshot is committed.
4. Background Guideline for the pharmacological treatment of hypertension in adults (World Health Organization, 2021)
  
  Guideline · World Health Organization · Edition Two snapshots of one edition, fetched on 2026-10-11: the WHO publication page, and the English PDF through the IRIS REST bitstream (843539 bytes, 61 pages counted from the file). The publication page states 48 pages. This cluster did not resolve the difference. A separate WHO summary edition exists and was not fetched. · Published 2021-08-24 · isbn: 978-92-4-003398-6
  
  Locator
  PDF page 9, Executive summary, paragraph 2, sentence 2
  
  How it applies
  WHO scope: adult, non-pregnant patients appropriately diagnosed with hypertension and counselled about lifestyle.
  
  Retrieved
  2026-10-11T19:11:40Z
  
  Source effective date
  2021-08-24
  
  Source state
  Current
  
  Snapshot hash
  57f6376d5c9bc4ea6c44873625547c8a5443d5a6ad8c8c422733681563db05fb
  
  Reuse basis
  CC BY-NC-SA 3.0 IGO, as the PDF states. Short quotations with attribution only. The non-commercial and share-alike terms need a decision on the atlas public data licence before any reuse beyond short quotation. Neither snapshot is committed.
5. Background Guideline for the pharmacological treatment of hypertension in adults (World Health Organization, 2021)
  
  Guideline · World Health Organization · Edition Two snapshots of one edition, fetched on 2026-10-11: the WHO publication page, and the English PDF through the IRIS REST bitstream (843539 bytes, 61 pages counted from the file). The publication page states 48 pages. This cluster did not resolve the difference. A separate WHO summary edition exists and was not fetched. · Published 2021-08-24 · isbn: 978-92-4-003398-6
  
  Locator
  PDF page 9, Executive summary, paragraph 4, sentence 4
  
  How it applies
  WHO says it built summary of findings tables with the GRADE approach.
  
  Retrieved
  2026-10-11T19:11:40Z
  
  Source effective date
  2021-08-24
  
  Source state
  Current
  
  Snapshot hash
  57f6376d5c9bc4ea6c44873625547c8a5443d5a6ad8c8c422733681563db05fb
  
  Reuse basis
  CC BY-NC-SA 3.0 IGO, as the PDF states. Short quotations with attribution only. The non-commercial and share-alike terms need a decision on the atlas public data licence before any reuse beyond short quotation. Neither snapshot is committed.

Guidance

Recommended: Hypertension treatment by nonphysician professionals, such as pharmacists and nurses

Applies to Adult

Adults with a confirmed diagnosis of hypertension. Recommendation 1a covers systolic 140 mmHg or higher or diastolic 90 mmHg or higher. Recommendations 4, 5 and 8 cover adults with hypertension who need medicine. WHO says the guideline targets non-pregnant adults who were appropriately diagnosed and counselled about lifestyle changes.
Not stated for this recommendation in the source
Global WHO guidance; national adoption not recorded
Adult

Follow-up Not applicable (recommendation context)

Issued by: World Health Organization
Guideline: Guideline for the pharmacological treatment of hypertension in adults (World Health Organization, 2021), edition Two snapshots of one edition, fetched on 2026-10-11: the WHO publication page, and the English PDF through the IRIS REST bitstream (843539 bytes, 61 pages counted from the file). The publication page states 48 pages. This cluster did not resolve the difference. A separate WHO summary edition exists and was not fetched.
Strength: Conditional recommendation, low-certainty evidence (GRADE. Section 2.5 of the WHO guideline (PDF page 17) says the guideline development group rated the certainty of evidence and developed the recommendations with the GRADE approach, and it defines a strong recommendation and a weak or conditional one.)
Effective: 2021-08-24 (The publication date on the WHO publication page.)
Jurisdiction: Global WHO guidance; national adoption not recorded
Supersession: Not checked

Basis: WHO suggests that medicine for hypertension can be provided by nonphysician professionals such as pharmacists and nurses, provided there is proper training, prescribing authority, specific management protocols and physician oversight.
Limitations. WHO labels this statement "Conditional recommendation, low-certainty evidence". The certainty above is that label. The conditions are part of the recommendation, and none of them was checked against any country's rules. Global WHO guidance written for adults who are not pregnant; national adoption is not recorded. No evidence review behind the recommendation was read by this cluster. The WHO publication page and the PDF disagree on the page count (48 versus 61); this was not resolved.

Clinical links

Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.

Claim, not a settled fact WHO 2021 8: with training, prescribing authority, protocols and physician oversight (conditional): Hypertension (high blood pressure) (Recommended for)
Applies to Adult
- Adults with a confirmed diagnosis of hypertension. Recommendation 1a covers systolic 140 mmHg or higher or diastolic 90 mmHg or higher. Recommendations 4, 5 and 8 cover adults with hypertension who need medicine. WHO says the guideline targets non-pregnant adults who were appropriately diagnosed and counselled about lifestyle changes.
- Not stated for this recommendation in the source
- Global WHO guidance; national adoption not recorded
- Adult
Follow-up Not applicable (recommendation context)
WHO suggests that medicine for hypertension can be provided by nonphysician professionals such as pharmacists and nurses, provided there is proper training, prescribing authority, specific management protocols and physician oversight.
Limitations. WHO labels this statement "Conditional recommendation, low-certainty evidence". The certainty above is that label. The conditions are part of the recommendation, and none of them was checked against any country's rules. Global WHO guidance written for adults who are not pregnant; national adoption is not recorded. No evidence review behind the recommendation was read by this cluster. The WHO publication page and the PDF disagree on the page count (48 versus 61); this was not resolved.

Record details

Record id: cardio:nonphysician-hypertension-treatment
Content hash: 0f694582bcb2a284948c6b3c5cc3784105c5cf64de19082cb7e0b47258137243